CA2929333C - Cell culture method comprising transfer to serum medium having the same species origin as the cells being cultured - Google Patents

Cell culture method comprising transfer to serum medium having the same species origin as the cells being cultured Download PDF

Info

Publication number
CA2929333C
CA2929333C CA2929333A CA2929333A CA2929333C CA 2929333 C CA2929333 C CA 2929333C CA 2929333 A CA2929333 A CA 2929333A CA 2929333 A CA2929333 A CA 2929333A CA 2929333 C CA2929333 C CA 2929333C
Authority
CA
Canada
Prior art keywords
cells
medium
cell
serum
mesenchymal stromal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2929333A
Other languages
English (en)
French (fr)
Other versions
CA2929333A1 (en
Inventor
Marian June STURM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Isopogen Pty Ltd
Original Assignee
Isopogen Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013904257A external-priority patent/AU2013904257A0/en
Application filed by Isopogen Pty Ltd filed Critical Isopogen Pty Ltd
Publication of CA2929333A1 publication Critical patent/CA2929333A1/en
Application granted granted Critical
Publication of CA2929333C publication Critical patent/CA2929333C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2929333A 2013-11-04 2014-11-03 Cell culture method comprising transfer to serum medium having the same species origin as the cells being cultured Active CA2929333C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2013904257 2013-11-04
AU2013904257A AU2013904257A0 (en) 2013-11-04 Cell culture method
PCT/AU2014/001031 WO2015061839A1 (en) 2013-11-04 2014-11-03 Cell culture method

Publications (2)

Publication Number Publication Date
CA2929333A1 CA2929333A1 (en) 2015-05-07
CA2929333C true CA2929333C (en) 2023-09-12

Family

ID=53003004

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2929333A Active CA2929333C (en) 2013-11-04 2014-11-03 Cell culture method comprising transfer to serum medium having the same species origin as the cells being cultured

Country Status (14)

Country Link
US (2) US9868936B2 (cg-RX-API-DMAC7.html)
EP (1) EP3066193B1 (cg-RX-API-DMAC7.html)
JP (2) JP6643999B2 (cg-RX-API-DMAC7.html)
KR (1) KR102314825B1 (cg-RX-API-DMAC7.html)
CN (1) CN105765059B (cg-RX-API-DMAC7.html)
AU (1) AU2014344795B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016009753B1 (cg-RX-API-DMAC7.html)
CA (1) CA2929333C (cg-RX-API-DMAC7.html)
ES (1) ES2984009T3 (cg-RX-API-DMAC7.html)
IL (1) IL245392B (cg-RX-API-DMAC7.html)
MX (1) MX2016005824A (cg-RX-API-DMAC7.html)
RU (1) RU2016119489A (cg-RX-API-DMAC7.html)
SG (1) SG11201603407VA (cg-RX-API-DMAC7.html)
WO (1) WO2015061839A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012048093A2 (en) 2010-10-08 2012-04-12 Osiris Therapeutics, Inc. Enhanced msc preparations
WO2015061839A1 (en) * 2013-11-04 2015-05-07 Sturm Marian June Cell culture method
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
US10420802B2 (en) 2015-12-10 2019-09-24 Aesthetics Biomedical, Inc. Topical formulation for skin care
CN109104869B (zh) * 2016-04-27 2022-07-01 日本乐敦制药株式会社 表达细胞表面标记物的间充质干细胞、包含该间充质干细胞的药物组合物及其制备方法
US20180185421A1 (en) * 2016-08-29 2018-07-05 Tokyo Metropolitan Government Composition comprising fecal microbiota
CN108925548A (zh) * 2017-05-24 2018-12-04 西比曼生物科技(香港)有限公司 一种冻存细胞制剂及细胞复苏方式
WO2019102268A1 (en) 2017-11-22 2019-05-31 Mesoblast International Sarl Cellular compositions and methods of treatment i
JPWO2020067443A1 (ja) * 2018-09-27 2021-08-30 テルモ株式会社 体細胞のシート化方法
CN110628700B (zh) * 2019-10-14 2023-10-17 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) 一种用于筛选细胞培养条件的标准方法
KR20220143092A (ko) * 2020-02-19 2022-10-24 메조블라스트 인터내셔널 에스에이알엘 만성 이식편 대 숙주 질환의 치료 방법
WO2021176001A1 (en) 2020-03-05 2021-09-10 Mesoblast International Sàrl Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells
US20230270791A1 (en) * 2020-07-31 2023-08-31 Rainbow (Rainbow Inc.) Platelet lysate derived from autologous platelets
US12577540B2 (en) 2020-12-10 2026-03-17 Sarepta Therapeutics, Inc. Suspension mode seed train development for adherent cells
EP4764493A1 (en) * 2024-12-18 2026-06-24 Beiersdorf AG Rejuvenating factors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142914A0 (en) * 1998-11-09 2002-04-21 Consorzio Per La Gestione Del Serum free medium for chondrocyte-like cells
ES2432118T3 (es) 2001-02-14 2013-11-29 Abt Holding Company Células madre adultas multipotentes, fuentes de estas, métodos para obtenerlas y mantenerlas, métodos de diferenciación de estas, métodos de uso de estas y células derivadas de estas
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
WO2004087885A2 (en) 2003-03-27 2004-10-14 Ixion Biotechnology, Inc. Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US11395865B2 (en) 2004-02-09 2022-07-26 DePuy Synthes Products, Inc. Scaffolds with viable tissue
DE102004055615A1 (de) 2004-11-16 2006-05-18 Universitätsklinikum Hamburg-Eppendorf In vitro aus Knochenmarkstammzellen differenzierte Retina-spezifische Zellen, ihre Herstellung und Verwendung
US7972767B2 (en) * 2005-05-09 2011-07-05 Olympus Corporation Method for culturing mesenchymal stem cell and method for producing biological tissue prosthesis
US7989205B2 (en) * 2005-10-06 2011-08-02 American Cryostem Corporation Cell culture media, kits and methods of use
EP1795588A1 (en) * 2005-12-07 2007-06-13 Cellerix, S.L. Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease
GB0814249D0 (en) * 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
WO2010043076A1 (zh) * 2008-10-17 2010-04-22 宁夏医科大学附属医院 适于临床应用的人胎盘间质细胞库的建立方法
WO2012149574A1 (en) * 2011-04-29 2012-11-01 Tissuetech, Inc. Methods of isolating cells
CN102965335A (zh) * 2011-09-01 2013-03-13 北京清美联创干细胞科技有限公司 用于间充质干细胞培养的试剂盒及其应用
WO2015061839A1 (en) 2013-11-04 2015-05-07 Sturm Marian June Cell culture method

Also Published As

Publication number Publication date
US9868936B2 (en) 2018-01-16
CN105765059B (zh) 2021-05-25
JP6947430B2 (ja) 2021-10-13
CA2929333A1 (en) 2015-05-07
EP3066193A1 (en) 2016-09-14
US20150307844A1 (en) 2015-10-29
EP3066193B1 (en) 2024-07-10
IL245392A0 (en) 2016-06-30
EP3066193C0 (en) 2024-07-10
BR112016009753B1 (pt) 2023-11-28
IL245392B (en) 2018-10-31
AU2014344795B2 (en) 2016-05-26
RU2016119489A (ru) 2017-12-11
KR102314825B1 (ko) 2021-10-20
JP2020022486A (ja) 2020-02-13
US20180112181A1 (en) 2018-04-26
EP3066193A4 (en) 2017-04-19
AU2014344795A1 (en) 2016-03-10
US11041144B2 (en) 2021-06-22
ES2984009T3 (es) 2024-10-28
JP2017501740A (ja) 2017-01-19
SG11201603407VA (en) 2016-05-30
CN105765059A (zh) 2016-07-13
KR20160070167A (ko) 2016-06-17
BR112016009753A2 (pt) 2018-05-02
WO2015061839A1 (en) 2015-05-07
MX2016005824A (es) 2016-11-18
JP6643999B2 (ja) 2020-02-12

Similar Documents

Publication Publication Date Title
US11041144B2 (en) Cell culture method
JP6266726B2 (ja) 放射線照射または化学物質による傷害を治療するための方法
JP6478243B2 (ja) 間葉系幹細胞を培養するための方法
ES2628129T3 (es) Tratamiento de la enfermedad vascular periférica utilizando células derivadas del posparto
JP7563976B2 (ja) 歯髄由来細胞の製造方法
JP2018118984A (ja) 肺疾患及び肺障害の炎症促進性メディエータのhUTC調節
RU2742308C2 (ru) Стромальные стволовые клетки жировой ткани для использования в лечении рефракторных сложных перианальных фистул при болезни крона
JP5431146B2 (ja) 免疫学的寛容および調節性前駆細胞
WO2007065927A1 (en) Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease
WO2020190672A1 (en) Cardiomyocyte-derived exosomes inducing regeneration of damaged heart tissue
AU2015284180B2 (en) Gonad-derived side population stem cells
US20100129329A1 (en) METHODS FOR USING ALDHbr CELLS TO SUPPLEMENT STEM CELL TRANSPLANTATION
HK1228953B (en) Cell culture method
HK1228953A1 (en) Cell culture method
BR112018068493B1 (pt) Uso de células-tronco estromais

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20191024

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 10TH ANNIV.) - STANDARD

Year of fee payment: 10

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241029

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241029

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241029

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD

Year of fee payment: 11

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251020

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251020